Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Medical Technology
  • GE HealthCare mulls $1B imaging chemicals maker deal: Financial Times

GE HealthCare mulls $1B imaging chemicals maker deal: Financial Times

September 13, 2026Posted inMedical Technology

GE HealthCare is said to be on the cusp of buying out radiopharmaceutical developer Sofie Biosciences, according to a report by the Financial Times.

Post navigation

Previous Post
therapeutic-family-camps-bring-healing-and-hope-to-aboriginal-children-in-remote-australia Therapeutic Family Camps Bring Healing and Hope to Aboriginal Children in Remote Australia
Next Post
J&J looking to offload orthopedics unit in $20B deal to Apollo: Bloomberg

Recent Posts

  • Fat-Derived Stem Cell Vesicles May Offer Multitarget Approach to Diabetic Microangiopathy
  • New Framework Sorts Stroke Vasculopathies by Biology, Not Just Imaging
  • MOF and COF Materials Show Promise for Detecting Bisphenols in Food
  • Animal Products Carry the Heaviest Water Footprint, Landmark Database Shows
  • Problematic Internet Use Tied to Higher Pregnancy Distress in Iranian Cross-Sectional Study

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • September 2024
  • August 2024
  • March 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top